Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

X4 Pharmaceuticals (XFOR) Other Operating Expenses (2018 - 2024)

Historic Other Operating Expenses for X4 Pharmaceuticals (XFOR) over the last 4 years, with Q2 2024 value amounting to $105.0 million.

  • X4 Pharmaceuticals' Other Operating Expenses changed N/A to $105.0 million in Q2 2024 from the same period last year, while for Mar 2025 it was $105.0 million, marking a year-over-year increase of 9187.19%. This contributed to the annual value of $105.0 million for FY2024, which is N/A changed from last year.
  • X4 Pharmaceuticals' Other Operating Expenses amounted to $105.0 million in Q2 2024.
  • In the past 5 years, X4 Pharmaceuticals' Other Operating Expenses ranged from a high of $105.0 million in Q2 2024 and a low of -$509000.0 during Q4 2022